Board
Screen
Heat
Cal
Watch
News
Blog
TV
Home
/
ROP.SW
Home
/
ROP.SW

SIX
CHF395.9
CHF395.9

Overview

Price performance
Low
CHF 387.00
High
CHF 395.90
Market closed. Last updated: Nov 4, 2026, 4:31 PM UTC
CHF 
395.90
4.90 (1.25%)
Average, 50 days
CHF 366.27
CHF 343.73
Open
CHF 389.20
Previous close
CHF 391.00
52-week high
CHF 405.90
Oct 30, 2026 (6 days ago)
52-week low
CHF 260.60
Nov 5, 2025 (13 months ago)
51.92%

Valuation & Estimates

Earnings

Financials

Insider Trading

Peer Analysis

Insights & Activity

Market Cap
273.20B
Volume
1 060 450
Total Return (3M)
10.68%
Total Return (1Y)
49.96%
13.97
Sector
Healthcare
Links
Tags
Healthcare
Drug Manufacturers - General
SIX
CH
Website
roche.com
About
Roche Holding AG is a prominent global entity primarily active in the pharmaceutical and diagnostics industries. Its extensive operations encompass numerous countries, including key markets such as Switzerland, Germany, the United States, Austria, the Netherlands, the United Kingdom, France, and Belgium, alongside a broader international presence. The company's pharmaceutical division is dedicated to developing and marketing a diverse range of medicinal products. These treatments target various therapeutic areas like oncology, neuroscience, infectious diseases, immunology, cardiovascular and metabolic disorders, ophthalmology, and respiratory conditions. Additionally, their portfolio addresses specific ailments such as anemia, cancer, dermatological issues, hemophilia, inflammatory and autoimmune disorders, neurological conditions, and transplantation. In the diagnostics sector, Roche supplies advanced in-vitro tests utilized for detecting and monitoring a wide array of diseases, including cancer, diabetes, Covid-19, hepatitis, and human papillomavirus. They also provide crucial diagnostic instruments and reagents to healthcare facilities. Furthermore, Roche is engaged in a research partnership with Synlogic, Inc., focused on identifying a novel synthetic biotic for the treatment of inflammatory bowel disease (IBD). This well-established organization, founded in 1896, maintains its corporate headquarters in Basel, Switzerland.

Frequently asked questions

ROP.SW · Roche Holding AG

01What is Roche Holding AG stock price today?

The current price of ROP.SW is CHF 395.90 — it has increased by 1.25% since the previous close. Data as of Nov 4, 2026.

02Is Roche Holding AG stock price growing?

ROP.SW is down 2.27% over the past week, up 14.52% over the past month and up 49.96% over the past year. The price is above its 200-day moving average of CHF 343.73.

03What is Roche Holding AG market cap?

Roche Holding AG has a market capitalization of CHF 273.2B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.

04Who are Roche Holding AG competitors?

Companies most comparable to Roche Holding AG include Novo Nordisk A/S, Eli Lilly and Company, Johnson & Johnson, AbbVie Inc. and Merck & Co., Inc.

05How volatile is ROP.SW stock?

In the latest trading session ROP.SW moved between CHF 387.00 and CHF 395.90, a range of 2.25% of its current price.

06What are ROP.SW stock 52-week high and low?

Over the past 52 weeks ROP.SW has traded between CHF 260.60 and CHF 405.90. The current price is 2.46% below its 52-week high.

Figures as of Nov 4, 2026. This information is provided for general purposes only and is not investment advice.